Barclays Reports 18 Profit Increase Raises Income Guidance Professional Title DuPont Announces Reverse Stock Split What It Could Mean for the Stock Japan Stocks Edge Lower as Nikkei 225 Declines 029 Oura Health Files Confidentially for IPO Signaling Potential Public Debut SP 500 Edges Higher as Tech Surge Overcomes Energy and Healthcare Slump Shares of Chinese Container Shipping Firms Decline After US Cartel Allegations COTY Q1 2026 Earnings EPS Misses Estimates Significantly Revenue Details Unavailable WhiteFiber Inc WYFI Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Shares Edge Higher NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 NGL Q1 2026 Earnings EPS Misses Estimates Stock Declines ASPS Q1 2026 Earnings EPS Exceeds Estimates by 349 Shares Surge MTNB Q4 2024 Earnings Narrowing Losses Surprise as Biotech Advances Pipeline Without Revenue Six Flags Entertainment FUN Modestly Higher as Stock Tests Key Support Zone Bogota Financial Corp BSBK Slips 118 as Stock Tests Key Support Near 800 Saratoga Investment Corp Note SAY Holds Steady Near Support as Bond Market Awaits Rate Cues Forte Biosciences Inc FBRX Edges Lower as Key Support Holds in Focus MasTec MTZ Retreats From Resistance Technicals Signal Caution After 17 Decline AnheuserBusch InBev Shares Slip After Sales Miss Estimates Chicago Atlantic Real Estate Finance Inc REFI Q1 2026 Earnings Earnings Miss Estimates Amid Higher Expenses Arteris Inc AIP Edges Higher as Bullish Momentum Builds Toward 3824 Resistance ALGT Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Discontinuation SSYS Q1 2026 Earnings Narrower Loss Surpasses Estimates Shares Edge Higher RIOT Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Bitcoin Mining Challenges Persist Parsons Corporation PSN Q1 2026 Earnings EPS Surges Past Estimates as Operational Execution Drives Performance CLW Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction DKS Q1 2026 Earnings EPS Surges 19 Above Estimates Stock Rises NGNE Q1 2026 Earnings EPS Misses Estimates as Biotech Continues RD Focus